FDA Adverse Event Death Summary report: N

ENDEAVOR SPRINT RX

MDR report key: 5387814 · Received January 25, 2016

Report

Report Number
9612164-2016-00084
Event Type
Death
Date Received
January 25, 2016
Date of Event
December 5, 2015
Report Date
December 28, 2015
Manufacturer
MEDTRONIC IRELAND
Product Code
NIQ
PMA / PMN Number
P060033
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DATE OF DEATH - DATE IS APPROXIMATE.

Description of Event or Problem · 1

IT WAS INTENDED TO USE AN ENDEAVOR SPRINT DRUG ELUTING STENT TO TREAT A SEVERELY CALCIFIED AND SEVERELY TORTUOUS LESION IN THE LAD. THE LESION HAD ALMOST 100 % STENOSIS AND TIMI GRADE 0. THE PATIENT ALSO HAD 50-70% STENOSIS IN THE PROXIMAL-MIDDLE LCX, 60% STENOSIS IN THE MIDDLE OF RGA, AND 70% STENOSIS IN THE DISTAL OF PDA, TIMI GRADE 3. THE DEVICE WAS INSPECTED PRIOR TO USE WITH NO ISSUES NOTED. THE LESION WAS PRE-DILATED WITH A 2.0 X 15 MM BALLOON AT A PRESSURE OF 12-16ATM. THE ENDEAVOR STENT WAS IMPLANTED AT A PRESSURE OF 12 ATM, HOWEVER THE STENT WAS ONLY PARTIALLY EXPANDED. THE PHYSICIAN THEN DILATED THE STENT USING A BALLOON AT 16-22 ATM. A VESSEL DISSECTION WAS THEN NOTED AT THE DISTAL OF THE STENT. THE PHYSICIAN THEN IMPLANTED A SECOND ENDEAVOR SPRINT STENT DISTALLY, AT 10 ATM. THE SECOND STENT WAS POST DILATED. THE STENT WAS COMPLETELY ADHERENT TO THE WALL, WITH NO RESIDUAL STENOSIS. THE PATIENT SUBSEQUENTLY EXPIRED DUE TO STENT THROMBOSIS - THE PHYSICIAN DETERMINED THAT THROMBUS CAUSED PATIENT'S DEATH AND THE EVENT WAS RELATED TO THE PRODUCT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
47433 ENDEAVOR SPRINT RX STENT, CORONARY, DRUG-ELUTING NIQ MEDTRONIC IRELAND

Patients

Seq Age Sex Outcome Treatment
1 00051 YR Death| R